4 / 9
Notes:
conference
series LLC Ltd
September 18-19, 2018 | Amsterdam, Netherlands
6
th
European Biopharma Congress
Euro Biopharma 2018
Clinical Pharmacology & Biopharmaceutics | ISSN : 2167-065X
Volume 7
Page 19
Nanomembrane microtubular devices for on- and off-chip
biomedical research and development
Nanomembranes are thin, flexible, and transferable and can be shaped into 3D
microtubular devices. This makes them attractive for a broad range of applications and
scientific research fields ranging from novel hybrid heterostructure devices to ultra-
compact 3D systems both on and off the chip. If nanomembranes are differentially
strained they deform themselves and roll-up into microtubular structures upon release
from their mother substrate. Rolled-up nanomembranes can be exploited to rigorously
compact electronic circuitry into microtubular systems. As rolled-up microtubes can
be easily tuned into the size range of single cells, they are perfectly suited to study
single cell behaviour in sensitive yet fully integrative lab-in-a-tube systems. As off-chip
components they address exciting environmental and biomedical applications. For
instance, ifmagnetic tubes or helices are combinedwith spermatozoa, such biomagnetic
cellular organisms offer new perspectives towards assisted reproduction technologies
and drug delivery protocols. However, while such micrometer sized robots show great
potential for medical applications they face equally big challenges when considering
in-vivo
operation.
Biography
Oliver G Schmidt is the Director of the Institute for Integrative Nanosciences at the Leibniz IFW Dresden, Germany.
His interests bridge across several disciplines, ranging from nanomaterials and nanoelectronics to microfluidics,
microrobotics and biomedical applications. He has received several awards: Otto-Hahn Medal from the Max-
Planck-Society in 2000, Philip-Morris Research Award in 2002, Carus-Medal from the German Academy of
Natural Scientists Leopoldina in 2005, and International Dresden Barkhausen Award in 2013. Most recently, he
was awarded the Gottfried Wilhelm Leibniz-Prize 2018 of the German Research Foundation. The Leibniz-Prize is
the most important research award in Germany for his outstanding work in the investigation, manufacturing and
innovative application of functional nanostructures.
schmidt@ifw-dresden.deOliver G Schmidt
Institute for Integrative Nanosciences, Germany
Oliver G Schmidt, Clin Pharmacol Biopharm 2018, Volume:7
DOI: 10.4172/2167-065X-C1-027